+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 100Years
All Genders
ID04886284

Evaluating Cefazolin Combined With Ertapenem Versus Placebo for Treatment of Methicillin-Susceptible Staphylococcus Aureus Bacteremia

Led by Todd C. Lee MD MPH FIDSA · Updated on 2026-11-02

60

Participants Needed

8

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the combination of cefazolin with ertapenem for treating methicillin-susceptible Staphylococcus aureus MSSA bacteremia, a serious bloodstream infection. This phase 2 randomized controlled trial explores whether adding ertapenem to cefazolin can improve clinical outcomes compared to cefazolin alone. MSSA bacteremia causes significant mortality, and current treatments have room for improvement, prompting this study as a sub-study of the SNAP trial. Participants will receive either ertapenem intravenously 1g daily infused over 2 hours for 5 days alongside cefazolin or a saline placebo infusion alongside cefazolin. The ertapenem targets a different bacterial protein than cefazolin, potentially enhancing treatment effectiveness. The study involves randomized assignment to one of two groups ertapenem plus cefazolin or placebo plus cefazolin. During the trial, participants will be assessed for clinical success by Day 5, and monitored up to 90 days for outcomes including blood culture clearance, clinical improvement, length of hospital stay, mortality, infections like C. difficile, and kidney injury. Safety monitoring includes tracking seizures and new bacterial colonization. Follow-up visits and evaluations will help researchers measure the impact of the combination therapy over time.

CONDITIONS

Brief Title

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Research Team

L

Lina Petrella

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here